18-Methoxycoronaridine, a non-toxic iboga alkaloid congener: effects on morphine and cocaine self-administration and on mesolimbic dopamine release in rats
Mechanisms Preclinical high
AI-extracted · unverified · confirm at source
BREAKTHROUGH: First demonstration that 18-MC provides equivalent anti-addictive efficacy to ibogaine (decreases morphine/cocaine self-admin) without tremors or cerebellar toxicity. Safer ibogaine analogue.
Dosing: 40–100 mg/kg (rat, i.p.) (intraperitoneal)